Dongwha Pharm, Foreigners Net Buy 4,000 Shares... Stock Price -2.62%
Dongwha Pharm has newly appeared among the top searched stocks.
As of 12:30 PM on the 25th, Dongwha Pharm is trading at 20,450 KRW, down 2.62% from the previous day. This represents a 15.54% increase compared to November 11. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myung Su and Fusidin).
Today, foreigners have a tentative net purchase of 4,000 shares of Dongwha Pharm, and institutions have a net purchase of 5,000 shares. Over the past five days, individual investors have net purchased 602,853 shares, while foreigners and institutions have net sold 483,056 shares and 1,252 shares, respectively.
On November 24, Dongwha Pharm was a market issue with a 25% rise following the news of approval for Phase 2 clinical trials of a COVID-19 treatment.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Samsung Labor-Management Strikes Dramatic Deal, But Issues Remain... 'Division Fairness and Operating Profit Link' Domino Effect
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.